GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of Germany: pricing, and what it actually costs here — 32 comments in the full submission. View in context.
1.6k
c/glp1uk·submitted 2 years ago by u/yusuf_ramos

Germany: pricing, and what it actually costs here

Questionbranch of 8 comments

Something I keep coming back to: Germany: pricing, and what it actually costs here. Supply notices from the regulator describe expected availability at a national level. They do not predict what any individual pharmacy has on the shelf next week. Scotland, Wales and Northern Ireland have their own arrangements. An…

Read the full submission and all 32 comments →

This branch

8 comments, started 2 years ago
u/ahmed_iyer0 points·2 years ago

Discharge from a specialist service at goal is a normal end point of that pathway. Whether prescribing continues in primary care afterwards is a local decision and is worth asking about at the start rather than at the end.

replysharereportpermalink
u/coring_the_stopper1 point·2 years ago

Agreed on keeping letters. Dates are what make an appeal or a re-referral possible.

replysharereportpermalink
u/dilara_weiss1 point·2 years ago

Correction: that threshold is your ICB’s, not a national one. They differ and they change by year.

replysharereportpermalink
u/bence_ibarra1 point·2 years ago

This. The monthly pricing tracker is the most useful thing on this board and it works because nobody is allowed to link anything.

replysharereportpermalink
load more comments (3) →
u/laila_wojcik1 point·2 years ago

the Irish scheme cap is the single most useful fact in this board

replysharereportpermalink

← back to the whole thread

About c/glp1uk

UK-specific access: NHS tier-3 and specialist weight-management pathways, the two-year waiting-list reality, private prescription routes and their monthly cost, pharmacy stock, MHRA supply notices, and how the UK rules differ from the US conversation that dominates most of the internet.

43kmembers
95submissions
Jan 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1uk rules
  1. No naming online pharmacies that prescribe without a consultation.
  2. Price posts need the date — UK private pricing moves monthly.
  3. NHS pathway questions: say which nation. England, Scotland, Wales and NI differ.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.